Skip to main content

Secretoneurin (SN): the first blood biomarker to accurately stratify mortality risk in patients with cardiac arrhythmia

Project description

First blood biomarker for assessment of mortality rate in cardiac arrhythmia

Call for proposal

H2020-SMEInst-2018-2020-1
See other projects for this call

Funding Scheme

SME-1 - SME instrument phase 1

Coordinator

CARDINOR AS
Address
Gaustadalleen 21
0349 Oslo
Norway
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EU contribution
€ 50 000